Cannabis Regulatory Tracker

Adult-Use (Recreational) States

As of April 2026, 24 states and the District of Columbia have legalized adult-use cannabis sales. Each state operates under its own regulatory framework with different licensing structures, tax rates, possession limits, and home cultivation rules.

Medical-Only States

An additional 14 states have medical cannabis programs without adult-use legalization. These range from comprehensive programs (Florida, Pennsylvania) to highly restrictive programs (limited qualifying conditions, low-THC only).

Key medical-only markets by size: Florida ($1.7B, vertically integrated), Pennsylvania ($1.2B+), Oklahoma ($600M, open licensing with oversaturation).

Federal Status

Cannabis remains a Schedule I controlled substance under federal law as of April 2026, despite significant executive action.

DEA Rescheduling

On December 18, 2025, President Trump signed Executive Order 14370, directing Attorney General Pam Bondi to “take all necessary steps to complete the rulemaking process related to rescheduling marijuana to Schedule III” in “the most expeditious manner.” Despite this directive, the process remains stalled due to an unresolved interlocutory appeal within the DEA. Administrative Law Judge hearings that began in December 2024 were postponed following allegations of improper ex parte communications between DEA officials and anti-rescheduling group Smart Approaches to Marijuana. As of April 2026, no briefing schedule has been set.

If completed, Schedule III would eliminate Section 280E (which creates effective tax rates of 70%+ for operators), reduce research barriers, and represent the first federal acknowledgment of cannabis’s medical value. It would not legalize recreational use, allow interstate commerce, or automatically resolve banking issues. Legal challenges are considered certain upon any final rule.

SAFE Banking Act

The SAFER Banking Act has passed the House and cleared the Senate Banking Committee (14–9 bipartisan vote, September 2023) but has never received a full Senate floor vote despite reportedly having 59+ supporters. Reintroduced in the 119th Congress as the “SAFER Banking Act of 2025.” In July 2025, 32 state and territorial attorneys general urged passage. Near-term prospects described as “muted” by analysts.

Federal Hemp Redefinition

Congress enacted a rider in FY2026 Agriculture Appropriations (November 2025) redefining hemp based on total THC (not just delta-9), prohibiting hemp-derived products with more than 0.4mg THC per serving. Takes effect November 2026.

2025–2026 State Developments

• Virginia — General Assembly passed retail sales legislation March 2026 (HB 642/SB 542). Sales commence January 1, 2027. 6% state excise + 1–3.5% local tax, cap of 350 retail licenses, $10M conversion fee for medical operators.
• Delaware — recreational retail opened August 2025 after FBI fingerprinting delays.
• Minnesota — state-licensed adult-use sales launched September 2025. $31M in four months, 466,000 transactions.
• Nebraska — voter-approved medical cannabis (67%+ support, Nov 2024) being implemented. First cultivation licenses issued October 2025; dispensaries remain unopened.
• Kentucky — medical cannabis launched January 2025.
• Florida — Amendment 3 received 56% (needed 60%) in 2024. New 2026 petition campaign has gathered 1M+ signatures.
• Pennsylvania — adult-use passed the House 102–101 in May 2025, voted down in Senate committee.